Our team has over 20 years of hands on toxicology experience and can be a great asset all along your efforts to achieve success.
 
Kumar Sripathirathan, Ph.D. is Co-Founder and Chief Executive Officer. Dr. Sripathirathan has numerous years of experience spanning academic research, industry and a contract laboratory. His experience includes extensive research in safety pharmacology and toxicology, and he has monitored and conducted studies in several countries.

 
Vivek Yadav, Ph. D. is Preclinical Study Director. Dr. Vivek Yadav is the study director for preclinical toxicology studies. He is focused on ensuring the quality of the studies in addition to timely execution. Dr. Yadav oversees studies of relevance to pharmaceutical, biotechnology, and cosmetic companies. Dr. Yadav has more than 9 years of research experience spanning both academia and industry. Dr. Yadav holds a Ph.D. in Pharmaceutical Sciences and began his career as a research pharmacologist at UT M D Anderson Cancer Center and OU Health Science Center, Oklahoma. He was involved there in preclinical drug development of compounds of interest studying pharmacokinetics, cellular toxicity, general toxicology, and clinical pathology. He also worked on different cancer tumor models including orthotopic and xenograft. He has a strong background and experience in conducting IND-enabling GLP and non-GLP formulation studies.

 
Vanmathy Vasudevan, is Co-Founder and Chief Operating Officer. Ms. Vasudevan, after her bachelor in accountancy her attention altered towards computing which in turn decided to graduated from University of Chicago, a prestigious school in midwest with masters in computer science. She has broad experience and knowledge in information technology including Enterprise Architecture; software development lifecycle; project risks management models and enterprise security including host vulnerability assessment.